LX4211 400 mg
Sponsors
Lexicon Pharmaceuticals
Conditions
HealthyHealthy Subjects
Phase 1
Study to Determine the Safety, Tolerability and Pharmacokinetics Following Multiple Doses of LX4211 in Healthy Subjects
CompletedNCT01916850
Start: 2013-08-31Updated: 2013-10-30
Study to Evaluate the Effect of Single Doses of LX4211 and Canagliflozin on Intestinal Glucose Absorption in Healthy Adult Subjects
CompletedNCT01916863
Start: 2013-08-31Updated: 2013-10-30